Skip to main content
Sanjivani Parenteral

Facilitated a successful Equity (Preferential Issue) fundraise for Sanjivani Parenteral

Sanjivani transaction details

Investor
-
Investee
Sanjivani Parenteral

Focus Sector
Pharmaceuticals
Date
January 2024

Sanjivani Parenteral operates in the pharmaceutical sector, specializing in the development, manufacturing, and marketing of sterile injectable and parenteral pharmaceutical products. Ashika Group had the pleasure of facilitating a successful Equity (Preferential Issue) raise for them fuelling their next phase of growth.